Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX)

Anti-epidermal growth factor receptor (EGFR) monoclonal antibody is a standard treatment of metastatic colorectal cancer (mCRC) and its most common adverse effect is a papulopustular acneiform rash. The aim of the CUTACETUX study was to characterize the skin inflammatory response associated with thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tougeron, David, Emambux, Sheik, Favot, Laure, Lecomte, Thierry, Wierzbicka-Hainaut, Ewa, Samimi, Mahtab, Frouin, Eric, Azzopardi, Nicolas, Chevrier, Jocelyn, Serres, Laura, Godet, Julie, Levillain, Pierre, Paintaud, Gilles, Ferru, Aurélie, Rouleau, Laetitia, Delwail, Adriana, Silvain, Christine, Tasu, Jean-Pierre, Morel, Franck, Ragot, Stéphanie, Lecron, Jean-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714491/
https://www.ncbi.nlm.nih.gov/pubmed/33299659
http://dx.doi.org/10.1080/2162402X.2020.1848058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714491/
https://www.ncbi.nlm.nih.gov/pubmed/33299659
http://dx.doi.org/10.1080/2162402X.2020.1848058

Ejemplares similares